BioRestorative Therapies(BRTX) - 2025 Q2 - Quarterly Report
2025-08-13 04:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-37603 BIORESTORATIVE THERAPIES, INC. (Exact name of registrant as specified in its charter) (State or other Jurisdictio ...
Microbot Medical(MBOT) - 2025 Q2 - Quarterly Report
2025-08-13 04:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from ____ to _____ Commission file number: 000-19871 175 Derby St., Bld. 27 Hingham, MA 02043 (Address of principal executive of ices) (781) 875-3605 (Registrant's T ...
Dawson(DWSN) - 2025 Q2 - Quarterly Results
2025-08-13 04:30
Exhibit 99.1 NEWS RELEASE Dawson Geophysical Company 508 W. Wall, Suite 800 Midland, TX 79701 DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2025 RESULTS MIDLAND, Texas, August 12, 2025/PR Newswire/Dawson Geophysical Company (NASDAQ: DWSN) (the "Company") today reported unaudited financial results for its second quarter ended June 30, 2025. Management Comment Tony Clark, Dawson's President and CEO, commented, "Due to the observed increase in demand for large integrated high-resolution, high channel count surveys ...
DURECT (DRRX) - 2025 Q2 - Quarterly Results
2025-08-13 04:30
收购交易 - Bausch Health将以每股1.75美元的价格收购DURECT,前期对价约为6300万美元,并可能支付高达3.5亿美元的销售里程碑款项[1][3] 收入和利润 - 2025年第二季度总收入为44.7万美元,净亏损230万美元,相比2024年同期的64.6万美元收入和370万美元净亏损有所改善[5][10] - 2025年第二季度运营亏损为280.3万美元,相比2024年同期的419.4万美元改善33.2%[10] - 2025年第二季度每股基本净亏损为0.07美元,相比2024年同期的0.12美元有所改善[10] 成本和费用 - 2025年第二季度研发费用为117.6万美元,相比2024年同期的224.7万美元下降47.7%[10] - 2025年第二季度销售、一般及行政费用为206.7万美元,相比2024年同期的256.6万美元下降19.4%[10] 其他财务数据 - 2025年第二季度其他收入为53.8万美元,主要来自93万美元的利息收入和44.5万美元的认股权证负债公允价值变动[10] - 截至2025年6月30日,现金及现金等价物和投资总额为670万美元,较2024年12月31日的1200万美元下降44.2%[5][12] - 截至2025年6月30日,公司总资产为1248.2万美元,较2024年底的1834.9万美元下降31.9%[12] - 截至2025年6月30日,股东权益为348.3万美元,较2024年底的913.1万美元下降61.9%[12]
Ares Acquisition II(AACT) - 2025 Q2 - Quarterly Report
2025-08-13 04:29
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the transition period from to Commission File No. 001-41691 ARES ACQUISITION CORPORATION II (Exact name of Registrant as specified in its charter) Cayman Islands 001-41691 98-1592 ...
Precigen(PGEN) - 2025 Q2 - Quarterly Report
2025-08-13 04:29
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-36042 PRECIGEN, INC. (Exact name of registrant as specified in its charter) Virginia 26-0084895 (State or other jurisdi ...
Mexco Energy (MXC) - 2026 Q1 - Quarterly Results
2025-08-13 04:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: August 12, 2025 (Date of earliest event reported) Mexco Energy Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) CO 1-31785 84-0627918 (IRS Employer Identification Number) 415 W. Wall Street, Suite 475 79701 Midland, TX (Zip Code) (Address ...
Erasca(ERAS) - 2025 Q2 - Quarterly Report
2025-08-13 04:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to ______________ Commission File Number: 001-40602 ERASCA, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 83-1217027 (State ...
Flanigan's Enterprises(BDL) - 2025 Q3 - Quarterly Report
2025-08-13 04:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from____________ to ____________ Commission File Number 001-06836 FLANIGAN'S ENTERPRISES, INC. (Exact name of registrant as specified in its charter) | Florida | 59 ...
cord Acquisition III(CNDB) - 2025 Q2 - Quarterly Report
2025-08-13 04:25
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant to Section 12(b) of the Act: | | Trading | | | --- | --- | --- | | Title of each class | Symbol(s) | Name of each exchange on which registered ...